genetic counseling conference, genetic counseling meeting, genetic counseling workshops, genetic counseling symposium, cpd points,cpd events,Genomics, Genetics, Genomic Medicine conferences,genetic counseling UK, genomic medicine meetings, genomic medici

Renowned Speakers

Dr. Gopal B. Krishnan

Promega Corporation USA

Dr. Peter Lajos Nagy

Columbia University USA

Dr. Igor A. Sobenin

Russian Cardiology Research and Production Complex Russia

Dr. Rosemarie Wahl

St. Maryâ€™s University USA

Dr. Patricia Berg

George Washington University USA

Margarita A Sazonova

Russian Cardiology Research and Production Complex Russian Federation

Dr. Mariusz Grzelakowski

Applied Biomimetic Inc. USA

Dr. Kathleen Wilson

U.T Southwestern Medical Center USA

Recommended Global Genetics & Molecular Biology Webinars & Conferences

Europe & UK

ADDICTION PSYCHIATRY 2025, Netherlands Agriculture 2024, Netherlands Allergic Conference 2024, France ALZHEIMERS- 2025, Spain

Asia Pacific & Middle East

BIOPOLYMER CONFERENCE 2024, UAE BIOTECH ASIA PACIFIC 2025, UAE BIOSIMILARS-2024, Indonesia BACTERIAL DISEASES 2024, UAE

Canada

Cancer Drugs 2024, Canada Clinical-Trials-2024, Canada

Genomic Medicine-2016

Sessions and tracks

Conference Series provides the perfect platform for global networking and we are truly delighted to invite you to attend our International Conference on Genetic Counseling and Genomic Medicine , during December 07-08, 2016 Madrid, U.K. Genomics-2016 is a global platform to discuss and learn about Genomics & Pharmacogenomics and its allied areas Bioinformatics, Transcriptomics, Biotechnology, Molecular Biology, Molecular Genetics and Genetic Engineering.

Track 1: Genomic medicine

Lately, another part of clinical prescription has developed with accentuation on the therapeutic and wellbeing ramifications of genomics. This is properly named genomic solution and holds incredible guarantee for human wellbeing. This new way to deal with human services utilizes the information of an individual's genomic make-up to recognize those that are at a higher danger of building up specific illnesses, and to mediate at a prior stage to keep these sicknesses. What's more, the genomic variety and particular genomic qualities will empower specialists to create devices to recognize poisons, supplements, microorganisms and other natural operators that could have negative or positive ramifications for individual or group wellbeing. This would likewise empower improvements of new medications, better medicines and cures.

"Genomic drug by Products Services - Global Forecast to 2018" finds that the Global Genomics Market earned livelihoods of $11.11 billion in 2013 and gages this business area to reach over $19.0 billion by 2018.

World Congress on Human Genetics October 31- November 02, 2016 Valencia, Spain; 4th International Conference on Integrative Biology, July 18-20, 2016, Berlin, Germany; International Conference on Molecular Biology, October 13-15, 2016 Dubai, UAE; International Conference on Genetic Counselling and Genomic Medicine August 11-12, 2016 Birmingham; 5th International Conference and Exhibition on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Symposium on Rice Functional Genomics, Sept 21-24, 2016, China; Ribosome structure and function 2016, 6–10 July 2016 | Strasbourg, France; 5th Genetics and Genomics Conference, June 1-3, 2016, Nanjing, China; Chromatin, Maintenance of Genome Stability 2016, March 7-10, 2017, Panama, Central America

Track 2: Genetic counseling

Genetic counseling is an administration that gives data and exhortation about hereditary conditions. These are conditions brought about by changes (known as transformations) in specific qualities and are generally gone down through a crew.

Hereditary directing is led by medicinal services experts who have been uncommonly prepared in the art of human hereditary qualities (a hereditary advisor or a clinical geneticist). These pros act as individuals from a social insurance group, giving data and backing to families who have individuals with conception deformities or hereditary issue and to families who might be at danger of an assortment of acquired conditions.

Hereditary guiding isn't a type of mental directing or psychotherapy and shouldn't be mistaken for advising treatment used to treat psychological wellness conditions, for example, uneasiness and sorrow.

Track 3: Gene Mapping

Determination of the relative positions of qualities on a DNA particle (chromosome or plasmid) and of the separation, in linkage units or physical units, between them.

Qualities with recombination frequencies under half are available in the same chromosome (connected). Two qualities that experience free combination, showed by a recombination recurrence of 50 percent, are either on nonhomologous chromosomes or are situated far separated in a solitary chromosome.

Microarrays were produced and popularized in the eighties. From that point forward, business sector has offered enormous development and consequently has seen a flood of players competing furiously for an offer or this business sector. The Global DNA and Gene Chip (microarray) business sector was esteemed at $760 million in 2010 and is relied upon to reach $1,425.2 million by 2015 developing at a CAGR of 13.4%. New item dispatches and assentions and coordinated efforts are the two fundamental methodologies embraced by the players to stay aggressive in this business sector. Despite the fact that quality expression has been the predominant utilization of these chips, growth diagnostics and treatment will lead the business sector in 2015 with an offer of 24.2% as more organizations put resources into analytic chips subsequent to ahead of schedule location of the malady and focused on treatment choices are still the unmet need of this business sector.

Track 4: Evolution of Novel Genes

Much advance in comprehension the development of new qualities has been proficient in the previous couple of years. Qualities are made by an assortment of transformative procedures, some of which produce copy duplicates of a whole quality, while others adjust prior hereditary components or co-select beforehand non-coding arrangement to make qualities with "novel" successions. These novel qualities are thought to add to unmistakable phenotypes that recognize living beings. The creation, advancement, and capacity of copied qualities are all around concentrated; be that as it may, the genesis and early development of novel qualities are not very much portrayed. We added to a computational way to deal with research these issues by incorporating vast similar phylogenetic investigation with practical and association information got from little scale and high-throughput tests.

International Conference on Clinical And Molecular Genetics, 28-30 November 2016 (Chicago, USA); 6^th International Conference on Genomics and Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); World Congress on Human Genetics, 31 October – 02 November 2016 (Barcelona, Spain); 2nd International Conference and Exhibition on Antibodies, July 14-15, 2016 (Philadelphia, USA); 16th International Congress of Immunology, August 21-26, 2016 (Melbourne, Australia); IMMUNOLOGY 2016™, AAI Annual Meeting, May 13–17, 2016 (Seattle, WA); 4^thInternational workshop on Cancer Genetic and Cytogenetic Diagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin and Epigenetics, 20-24 Mar 2016 (Whistler, Canada)

Track 5: Biomarkers

A biomarker, or organic marker, regularly alludes to a quantifiable pointer of some natural state or condition. The term is additionally rarely used to allude to a substance the vicinity of which shows the presence of a living creature. Extra, life structures are known not to novel chemicals, including DNA, into the air as confirmation of their vicinity in a specific area. Biomarkers are frequently measured and assessed to look at typical natural routines, pathogenic procedures, or pharmacologic reactions to a helpful mediation. Biomarkers are utilized as a part of numerous experimental fields.

International Conference and Expo on Molecular and Cancer Biomarkers September 15-17, 2016 Berlin, Germany; 4th International Conference on Integrative Biology, July 18-20, 2016 Berlin; 7th International Conference on Biomarkers and Clinical Research, November 28-30, 2016 Baltimore, USA; International Conference on Biochemistry October 13-15, 2016 Kuala Lumpur, Malaysia; International Conference on Protein Engineering, October 26-28, 2015 Chicago, USA; Biomarker Summit, 21–23 March 2016, San Diego, United States; 18th International Conference on Biomarkers and Clinical Medicine, 16-17 May, 2016, Paris, France; Circulating Biomarkers World Congress 2016, 21-22 March, 2016, Boston, USA; The Biomarker Conference, 18 - 19 February 2016, San Diego, USA; Cancer Molecular Markers, 7-9, March 2016, San Francisco, USA

Track 6: Genetic engineering techniques

Genome altering is a capable strategy that has as of now been a distinct advantage in helping researchers to comprehend the parts of qualities in wellbeing and illnesses. It co-picks the regular resistant protections of microscopic organisms to make what is frequently depicted as sub-atomic scissors. These can remove, additionally supplant, strands of DNA with awesome exactness. It is conceivable to change single letters of the DNA code.

Quality altering is quickly advancing from being an examination/screening apparatus to one that guarantees essential applications downstream in medication advancement, cell treatment and bioprocessing.

4th International Conference on Integrative Biology, July 18-20, 2016, Berlin, Germany; 2nd International Conference on Transcriptomics August 18-20, 2016 Portland, Oregon USA; International Conference on Next Generation Sequencing July 21-22, 2016 Berlin, Germany; World Congress on Human Genetics October 31- November 02, 2016 Valencia, Spain; 18th International Conference on Human Genetics, February 25 - 26, 2016, London, United Kingdom; Visualizing biological data, 9–11 March 2016, Heidelberg, Germany; 1st Annual International Congress of Genetics, April 25-28, Dalian, China; Chromatin and Epigenetics, March 20-24, 2016, British Columbia, Canada; Game of Epigenomics, April 24-28, 2016 in Dubrovnik

Track 7: Transgenic Research

A transgene is a quality or genetic material that has been exchanged normally, or by any of various hereditary designing procedures starting with one life form then onto the next. The presentation of a transgene can possibly change the phenotype of a living being. Amid hereditary designing, DNA is embedded into a plant's genome, and such insertions are regularly joined by the insertion of extra DNA, cancellations and/or modifications. These hereditary changes are by and large known as insertional impacts, and they can possibly offer ascent to unintended attributes in plants. What's more, there are numerous other hereditary changes that happen in plants both suddenly and as a consequence of ordinary reproducing hones. Gene changes like insertional impacts happen in plants, in particular as an aftereffect of the development of transposable components, the repair of twofold strand breaks by non-homologous end-joining, and the intracellular exchange of organelle DNA. In view of this similitude, insertional impacts ought to display a comparative level of danger as these other hereditary changes in plants, and it is inside of the setting of these genetic changes that insertional impacts must be considered.

Track 8: Novel medical Devices

Specialists are frequently on the bleeding edge of development on the grounds that our clinical foundation and hands-on utilization of restorative gadgets permits us to plainly see the deficiencies of existing innovation. Whether it is a stapler failure to discharge, an unbalanced laparoscopic instrument, or a problematic bio prosthesis, as the "end-client," the specialist is frequently the first to perceive developing issues with existing gadgets and distinguish ranges of patient care that need change.

Organizations in the North America and Asia Pacific therapeutic gadgets industry are more idealistic about their development prospects than their partners in Europe. This is mostly in light of the lukewarm financial development displayed by European nations in the later past. On the other hand, even in therapeutic gadget showcases that hold an inspirational viewpoint, deals increases are required to stay unassuming. Therapeutic hardware is a developing pattern in the present-day scene of the human services industry. A few medicinal hardware rental organizations in the business sector are putting forth restored gadgets for purchasers, who request more current forms of existing gear at a more reasonable expense. Henceforth, the worldwide medicinal hardware rental business sector is expected to remain a feasible and suitable alternative for most buyers within a reasonable time-frame. The worldwide restorative hardware rental business sector was recorded at US$33,417.4 million in 2013 and, at a CAGR of 5.8% amid the figure time of 2014 to 2020, will achieve an estimation of US$49,112.8 million by 2020.

Track 9: Tumor Markers

Tumor is considered as the most critical reason for horribleness and mortality over the world and early discovery of the same is fundamental for the most obvious opportunity with regards to prevention. Tumor markers are atoms found in pee, blood and body tissues. It is a protein which is found in substantial sums in vicinity of types of disease. Subsequently measuring the levels of tumor markers might help in identifying the vicinity of malignancy. Vicinity of a tumor in body fortifies the creation of tumor markers from tumor or non-tumor cells. Most tumor markers are proteins. For some reasons, tumor marker itself is normally insufficient to analyse or discount malignancy. Studies are being done to figure out whether tumor markers can be utilized as a part of ahead of schedule recognition and finding of disease.

Right now, malignancy is the one of the main sources of death in the created nations like North America and Europe. North America holds the biggest piece of the pie in tumor marker testing and is trailed by Europe because of inconceivable disclosures and advancements being done in these areas for recognizing the disease in its initial stages. the worldwide Point-Of-Care Diagnostic Market by Products (Glucose Monitoring and Infectious Diseases Testing Kits, Cardiac and Tumor Markers) POC diagnostics market over the gauge time of 2013 to 2018.The business sector is ready to develop at a CAGR of 9.3% from 2013 to 2018, to achieve $27.5billion by 2018. Starting 2013, North America (involving the U.S., Canada, and Mexico) held the biggest offer of the worldwide POC diagnostics market. This expansive offer is fundamentally credited to the colossal and expanding addressable patient populace base.

Track 10: Molecular Medicine

Molecular Medicine is a wide field comprehends the ordinary body working and infection pathogenesis at the sub-atomic level by utilizing physical, synthetic, natural and restorative strategies with the objective to create sub-atomic intercessions to right them. Atomic prescription is the use of Molecular Biology and Molecular Genetics to the comprehension of human wellbeing and malady. It plans to see how wellbeing is kept up and the starting points and components of human maladies. The sub-atomic pharmaceutical point of view stresses cell and sub-atomic marvels and mediations instead of the past applied and observational spotlight on patients and their organs.

The worldwide Molecular Medicine was esteemed at $2.9 billion in 2012 and is ready to reach $7.5 billion by 2017 at a CAGR of 20.9%. The development of the Molecular Medicine is driven by lessening in expense of DNA sequencing, expanding government activities and subsidizing, and developing use Molecular Medicine in medication revelation and biomarkers improvement forms. It is normal that the business sector will offer open doors for Molecular Medicine arrangements makers with the presentation and appropriation of up and coming advancements, for example, Nano pore sequencing and distributed computing.

Track 11:Next generation sequencing

Next-generation sequencing (NGS), .otherwise called greatly parallel sequencing, speaks to a viable approach to catch a lot of genomic data. Cutting edge sequencing is reforming therapeutic hereditary qualities and sooner rather than later will infest every single restorative field. Next-generation sequencing (NGS) advances are empowering synchronous sequencing of all applicable infection qualities, the exome or even the whole genome of patients looking for an atomic finding.

International Conference on Next Generation Sequencing, July 21-22, 2016 Berlin, Germany; 4th International Conference on Integrative Biology, July 18-20, 2016, Berlin, Germany; 6th International Conference on Genomics & Pharmacogenomics, September 12-14, 2016 Berlin, Germany; International Conference on Genetic Counselling and Genomic Medicine August 11-12, 2016 Birmingham; International Conference on Molecular Biology, October 13-15, 2016 Dubai, UAE; 6th Next Generation Sequencing Conference, May 25-26, 2016, Boston, USA; Genetics in Forensics Congress, 14-15, March 2016, London, UK; ICHG 2016, April 3-7, 2016, Japan; Genome Editing and Gene Modulation Congress, 6-8 April, 2016, Oxford, UK; 4th International Conference on Bioinformatics and Computational Biology, February 2-3, 2016, Kuala Lumpur, Malaysia

Track 12: Pharmacogenetics

Pharmacogenetics is the investigation of acquired hereditary contrasts in medication metabolic pathways which can influence singular reactions to tranquilizes, both as far as remedial impact and in addition unfriendly impacts. Pharmacogenomics utilizes data around a man's hereditary cosmetics, or genome, to pick the medications and drug dosages that are liable to work best for that specific individual. This new field joins the art of how medications work, called pharmacology, with the investigation of the human genome, called genomics.

Research around there has prompted key disclosures, which have offered our comprehension of the reasons why people some assistance with differing in the way they handle drugs, and at last in the way they react to tranquilizes, either as far as adequacy or lethality. On the other hand, very little of this learning has been deciphered into clinical practice, most medication quality affiliations that have some proof of clinical legitimacy have not advanced to clinical settings. Progresses in genomics since 2000, including the prepared accessibility of information on the variability of the human genome, have given us uncommon chances to comprehend variability in medication reactions, and the chance to consolidate this into patient consideration. This is just prone to happen with a precise methodology that assesses and beats the distinctive translational crevices in taking a biomarker from disclosure to clinical practice. In this article, I investigate the historical backdrop of pharmacogenetics, evaluate the ebb and flow condition of exploration around there, and complete off with proposals for advancing in the field later on.

Track 13: Global DNA and Gene Chip (Microarrays)

DNA microarrays are an innovation used to quantify the expression levels of a large number of qualities together and now and again, all qualities in a genome in the meantime. There are two sorts of DNA microarrays, cDNA (correlative DNA), and oDNA (oligonucleotide DNA) with oDNA overwhelming the business sector with an offer of just about 98%. The worldwide DNA and quality chip (Microarray) market offers huge development potential and has seen the passage of various players taking a stab at an offer in this business sector.

The worldwide DNA and quality chip (microarray) business sector was esteemed at $760 million in 2010 and is relied upon to reach $1,425.2 million by 2015 developing at a CAGR of and 13.4%. Quality expression right now frames the biggest application market as quality expression items have assorted use in regions, for example, clinical diagnostics, biodefense, and farming that are increasing colossal government subsidizing. While this application contributed 28% to the worldwide DNA and quality chip (microarray) market incomes in 2010, tumor finding and treatment application is relied upon to overwhelm the applications market by 2015; representing around 24% offer in the business sector

Track 14: Chromosomal Abnormalities

Chromosomes are the structures that hold qualities. Qualities are the individual guidelines that advise our bodies how to create and work; they represent physical and therapeutic attributes, for example, hair shading, blood classification and weakness to disease. Many chromosomes have two sections, called "arms," isolated by a squeezed district known as the centromere. The shorter arm is known as the "p" arm. The more drawn out arm is known as the "q" arm.A picture, or chromosome guide, of every one of the 46 chromosomes is known as a karyotype. The karyotype can distinguish anomalies in the structure or the quantity of chromosomes.

There are numerous sorts of chromosome anomalies. In any case, they can be sorted out into two fundamental gatherings: numerical irregularities and auxiliary variations from the norm.

• Numerical Abnormalities: When an individual is missing one of the chromosomes from a couple, the condition is called monosomy. At the point when an individual has more than two chromosomes rather than a couple, the condition is called trisomy.

• Structural Abnormalities: A chromosome's structure can be adjusted in a few ways.

Translocations: A bit of one chromosome is exchanged to another chromosome. There are two primary sorts of translocation. In an equal translocation, fragments from two unique chromosomes have been traded. In a Robertsonian translocation, a whole chromosome has appended to another at the centromere.

Most chromosome irregularities happen as a mischance in the egg or sperm. In these cases, the variation from the norm is available in each cell of the body. A few irregularities, be that as it may, happen after origination; then a few cells have the variation from the norm and some do not. Chromosome anomalies can be acquired from a guardian, (for example, a translocation) or be "once more" (new to the person). This is the reason, when a kid is found to have an irregularity, chromosome studies are regularly performed on the often.

Track 15: Eco genomics

An entire scope of society autonomous innovations have risen as of late those are upsetting our comprehension of the microbial biosphere. Boss amongst these are succession construct systems that depend with respect to shabby high-throughput sequencing of DNA and RNA extricated specifically from natural specimens (metagenomics and metatranscriptomics individually). So also, mass spectrometry-based distinguishing proof of peptides and little atoms has come to the stage that it is presently conceivable to recognize numerous proteins (metaproteomics) and metabolites (metabolomics) in natural examples. In parallel, cell sorting and entire genome enhancement routines are making single cell genomics a reality, giving a characteristic supplement to "entire" group portrayal systems. One other essential exploratory methodology, likewise progressing quickly, is cell imaging that gives a high-determination spatial structure on which to overlay sub-atomic information. These methods can be joined into an incorporated environmental structure utilizing computational advances and new displaying approaches, which we on the whole characterize as 'Eco genomics'.

Track 16: Clinical genomics

Clinical genomics is the utilization of genome sequencing to educate quiet finding and mind. Clinical genomics is another and quickly evolving field. Learning of the human genome is a long way from complete, yet there are as of now uses for hereditary and genomic data in the centre. Clinical genomics is the application and incorporation of genomic and other information—including useful genomics, genome structure, genome-scale populace hereditary qualities, epigenomics, proteomics, frameworks examination and pharmacogenomics—to better comprehend the hereditary bases of medication reaction and ill.

The Personalized Medicine, World Conference 24-27 January, 2016, San Francisco, USA; International Conference on Clinical and Molecular Genetics, November 28-30, 2016 Chicago, USA; 5th International Conference and Exhibition on Metabolomics, May 16-18, 2016 Osaka, Japan; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; 5th International Conference on Tissue Science and Regenerative Medicine September 12-14, 2016 Berlin, Germany; American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting, March 8-12, 2016, Tampa, USA; Belgian Society of Human Genetics and Dutch Society for Human Genetics Joint Meeting 2016 (NVHG BESHG 2016), February 4-5, 2016, Leuven, Belgium; An International Symposium of the Association of Biomolecular Resource Facilities, February 20-23, 2016, Florida, USA; 14th Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine Congress, November 26-29, 2016,Taipei, Taiwan; Personalized Medicine, July 10-15, 2016, Hong Kong, China

Track 17: Microbial genetics

Microbial genetics is a branch of knowledge inside of microbiology and hereditary building. It thinks about the hereditary qualities of little (miniaturized scale) life forms; microscopic organisms, archaea, infections and some protozoa and growths. This includes the investigation of the genotype of microbial species furthermore the expression framework as phenotypes.

Subsequent to the disclosure of microorganisms by two Fellows of The Royal Society, Robert Hooke and Antoni van Leeuwenhoek amid the period 1665-1885 they have been utilized to study numerous procedures and have had applications in different territories of study in hereditary qualities. For instance: Microorganisms' quick development rates and short era times are utilized by researchers to study advancement. Microbial hereditary qualities additionally has applications in having the capacity to study forms and pathways that are like those found in people, for example, drug digestion system.

Utilizations of microbial hereditary qualities:

Microorganisms are in a perfect world suited for biochemical and hereditary qualities ponders and have made tremendous commitments to these fields of science, for example, giving data on the hereditary code and the regulation of quality action. Jacques Monod and François Jacob utilized Escherichia coli, a kind of microscopic organisms, with a specific end goal to add to the operon model of quality expression, which set out the premise of quality expression and regulation. Moreover the genetic procedures of microorganisms are like those in multi-cell life forms permitting scientists to accumulate data on this procedure too. Another bacterium which has enormously added to the field of hereditary qualities is Thermus aquaticus, which is a bacterium that endures high temperatures. From this microorganism researchers detached the protein Taq polymerase, which is presently utilized as a part of the effective trial procedure, Polymerase chain reaction(PCR). Furthermore the improvement of Recombinant DNA innovation through the utilization of microscopic organisms has prompted the conception of cutting edge Genetic building and Biotechnology.

International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 4th International Conference on Integrative Biology July 18-20, 2016 Berlin, Germany; International Conference on Microbial Physiology and Genomics October 20-22, 2016 Rome, Italy; 4th International Conference on Clinical Microbiology and Microbial Genomics October 05-07, 2015 Philadelphia, USA; 2nd World Congress and Expo on Applied Microbiology October 31-November 02, 2016 Istanbul, Turkey; 18th International Conference on Clinical Microbiology and Microbial Genomics, June 9 - 10, 2016, San Francisco, USA; 18th International Conference on DNA and Microbial Genome Resources, February 11 - 12, 2016, Kuala Lumpur, Malaysia; 18th International Conference on Microbial Genome Resources and Clinical Microbiology, January 12 - 13, 2016, Zurich, Switzerland; 18th International Conference on Molecular Genetics and Microbiology, February 25 - 26, 2016, London, United Kingdom

Track 18: Cytogenetic

Cytogenetic is a branch of hereditary qualities that is worried with the investigation of the structure and capacity of the cell, particularly the chromosomes. It incorporates routine examination of G-joined chromosomes, other cytogenetic banding methods, and additionally sub-atomic cytogenetics, for example, fluorescent in situ hybridization (FISH) and relative genomic hybridization (CGH).

Progresses now concentrate on atomic cytogenetics including computerized frameworks for checking the consequences of standard FISH arrangements and methods for virtual karyotyping, for example, near genomic hybridization exhibits, CGH and Single nucleotide polymorphism clusters.

Track 19: Genetically modified organisms

A genetically modified organism (GMO) is any living being whose hereditary material has been changed utilizing hereditary designing systems (i.e. hereditarily designed living being). GMOs are the wellspring of pharmaceuticals and hereditarily adjusted sustenance’s and are likewise generally utilized as a part of logical exploration and to create different merchandise. The term GMO is near the specialized legitimate term, 'living changed creature', characterized in the Cartagena Protocol on Biosafety, which controls universal exchange living GMOs (particularly, "any living life form that has a novel mix of innate material procured through the usage of current biotechnology").

An all the more particularly characterized sort of GMO is a "Transgenic Organism". This is a creature whose hereditary cosmetics have been modified by the expansion of hereditary material from another, inconsequential living being. This ought not be mistaken for the more broad route in which "GMO" is utilized to arrange hereditarily modified life forms, as normally GMOs are creatures whose hereditary cosmetics has been adjusted without the expansion of hereditary material from an irrelevant life form.

The primary hereditarily adjusted mouse was in 1981, the first plant was created in 1983 and the first hereditarily altered human (changed mitochondrial DNA) was conceived on July 21, 1997.

Track 20: Genetic Disorders Tests

A hereditary issue is a hereditary issue brought about by one or more anomalies in the genome, particularly a condition that is available from conception (inherent). Most hereditary issue are entirely uncommon and influence one individual in each few thousands or millions.

Hereditary scatters might possibly be heritable, i.e., went down from the folks' qualities. In non-heritable hereditary issue, imperfections might be brought about by new transformations or changes to the DNA. In such cases, the imperfection might be heritable on the off chance that it happens in the germ. The same ailment, for example, a few types of disease, might be brought on by an acquired hereditary condition in a few individuals, by new transformations in other individuals, and for the most part by ecological reasons in still other individuals. Whether, when and to what degree a man with the hereditary imperfection or irregularity will really experience the ill effects of the ailment is quite often influenced by the ecological variables and occasions in the individual's improvement.

Hereditary testing is a kind of medicinal test that recognizes changes in chromosomes, qualities, or proteins. The consequences of a hereditary test can affirm or preclude a suspected hereditary condition or decide a man's possibility of creating or going on a hereditary issue. More than 1,000 hereditary tests are right now being used, and more are being created. A few systems can be utilized for hereditary testing: • Molecular hereditary tests (or quality tests) study single qualities or short lengths of DNA to distinguish varieties or changes that prompt a hereditary issue. • Chromosomal hereditary tests investigate entire chromosomes or long lengths of DNA to check whether there are huge hereditary changes, for example, an additional duplicate of a chromosome, that cause a hereditary condition.

Track 21: Pedigree construction

The investigation of acquired Mendelian attributes in people should depend on perceptions made while working with individual families. Established cross preparation reproducing tests as performed by Mendel are not permitted in people! Human geneticists are not permitted to specifically breed for the attributes they wish to think about! One of most effective apparatuses in human hereditary studies is family investigation. At the point when human geneticists first started to distribute family thinks about, they utilized an assortment of images and conventions. Now there are settled upon guidelines for the development of families.

Eras are joined by a vertical line reaching out down from the mating line to the cutting edge. Offspring of a mating are associated with a flat line, called the sib ship line, by short vertical lines. The offspring of a sib ship are constantly recorded altogether of conception, the most seasoned being on the left. Once in a while to disentangle a family one and only parent is demonstrated, the other is overlooked. This neither implies parthenogenic advancement nor does it connote divinely enlivened origination, it only means the guardian forgot is not from the family being concentrated on and is genotypically homozygous ordinary for the quality being considered.

Track 22: Polygenic inheritance

Polygenic inheritance includes the communication of more than one sets of qualities to decide characteristics, including skin, hair and eye shading, tallness, weight and knowledge. In these samples an extensive variety of variety exists. Nature likewise assumes a part in the last appearance or phenotype. A characteristic represented by more than one quality is called polygenic. The greater part of our phenotypic qualities is a consequence of expression and collaboration between different qualities and their items. Legacy of such characters can termed as polygenic legacy. Polygenic legacy happens when one trademark is controlled by two or more qualities. Frequently the qualities are huge in amount however little basically. Samples of human polygenic legacy are tallness, skin shading, eye shading and weight. Polygenes exist in different living beings, too. For e.g.: Drosophila, for occurrence, show polygeny with qualities, for example, wing morphology, swarm number and numerous others.

A few attributes are controlled by the joined impact of more than one set of qualities. These are alluded to as polygenic or constant, characteristics. A case of this is human stature. The consolidated size of the majority of the body parts from head to foot decides the tallness of a person. There is an added substance impact. The sizes of these body parts are, thus, controlled by various qualities. Human skin, hair, and eye shading are additionally polygenic qualities since they are affected by more than one allele at various loci. The outcome is the impression of ceaseless degree in the outflow of these attributes.

Track 23: Prenatal diagnosis

Pre-birth diagnostics is a system for testing of sicknesses before the conception of a tyke, to decide certain inheritable issue, for example, chromosome irregularities, Down's disorder, hereditary infections, neural tube deformities, and different conditions. It can be led by different systems of screening, regular testing, hereditary testing and different measures in instances of high hazard identified with the conception of a tyke.

Sometimes, the tests are directed to figure out whether the hatchling will be prematurely ended, however doctors and patients additionally think that its valuable to analyse high-hazard pregnancies early with the goal that conveyance can be booked in a tertiary consideration healing facility where the child can get suitable consideration.

There are three purposes of pre-birth analysis: (1) to empower auspicious medicinal or surgical treatment of a condition before or after conception, (2) to allow the folks to prematurely end a hatchling with the analysed condition, and (3) to allow folks to "get ready" mentally, socially, monetarily, and therapeutically for an infant with a wellbeing issue or incapacity. Having this data ahead of time of the conception implies that medicinal services staff and in addition folks can better set themselves up for the conveyance of a kid with a wellbeing issue. For instance, Down disorder is connected with heart abandons that might require mediation quickly upon conception. Numerous hopeful folks might want to know the sex of their child before conception.

Track 24: Reprogenetics

Reprogenetics is the utilization of conceptive and hereditary advancements to choose and hereditarily change developing lives with germinal decision innovation with the end goal of human upgrade. Be that as it may, a report by the Hastings Centre extensively characterized reprogenetics as any "creation, use, control, or capacity of gametes or developing lives." The term was authored by Lee M. Silver, an educator of atomic science at Princeton University.

In Silver's detailing, reprogenetics will include propels in various advancements not yet accomplished, but rather not inalienably outlandish. Among these are enhancements in translating the impacts of various articulations of DNA, the capacity to gather expansive quantities of incipient organisms from females, and a far higher rate of reinsertion of foetuses into host moms. The finished result, as per Silver, is that those folks who can bear the cost of it will have the capacity to select the hereditary attributes of their own kids, which Silver says will trigger various social changes in the decades after its execution. Conceivable early applications, then again, may be closer to disposing of sickness qualities went on to youngsters.

Track 25: Teratogenesis and their effects

Teratology is the science that studies the reasons, instruments, and examples of strange advancement. Advancement of information and society prompted the acknowledgment that reasons for innate formative issue (CDDs) may be brought on by different mechanical impacts, foetal ailments, and impeded or captured improvement of the developing life and embryo. Teratogenesis is procedure with edge level impact. Teratology is the science that studies the reasons, systems, and examples of unusual advancement. Formative issue present during childbirth are called innate peculiarities, conception deformity or intrinsic distortion. Intrinsic oddities are of four clinically huge sorts: abnormality, interruption, misshaping and dysplasia. Teratogen is component that is available in environment in so high sum that it can expand event of incipient organism danger sign up to fundamental recurrence in non-uncovered populace.

Essential morphogenetic forms amid the blastogenesis period, which reaches out all through the initial 4 wk. of improvement, from preparation until the end of the gastrulation stage (days 27 to 28 post conception), can be modified and bring about auxiliary variations from the norm, including examples of various inborn peculiarities (MCAs) emerging from formative field imperfections. Serious harm might bring about death of the result of origination or, due to the pluripotential way of the phones; the harm might be remunerated permitting advancement to proceed in an ordinary manner.

Track 26: Integration of genomics data

Genomic information coordination—the procedure of factually consolidating various wellsprings of data from practical genomics examinations to make expansive scale forecasts—is turning out to be progressively common. Numerous strides are important to coordinate genomic learning into clinical consideration, including precise annotation of the impact of genomic variations regarding genome capacity, relationship of variations with sickness finding or visualization, and determination of clinical utility of genomic data (a great parity of advantages to hazards as far as suggestions for wellbeing results and individual effect to the patient).

Track 27: Clinical applications and diagnostics

Applications like — tumor-based screening, family history–directed choice backing, pharmacogenomics, and indicative genome sequencing—show that genomic pharmaceutical is no more on the limit; it has arrived. Genomic medication an optimistic term 10 years prior is picking up energy over the whole clinical continuum from danger appraisal in solid people to genome-guided treatment in patients with complex ailments. Notable illustrations include: differential finding of single quality ailments, neonatology and oncology. Different applications incorporate sequencing innovation: the driver of genomic prescription, tumor sequencing for disease pharmacogenomics, clinical sequencing and demonstrative difficulties, Non-intrusive growth.

Track 28: Genetic Testing Market

Genetic testing is the most beneficial and quickly extending section of sub-atomic diagnostics. It is the variety of systems utilized for the investigation of DNA, RNA, and protein. It is utilized as a restorative apparatus to decide the hereditary deformities connected with a specific ailment. Hereditary testing is likewise utilized as a part of non-clinical applications, for example, paternity testing and crime scene investigation. In clinical applications, the essential centre of hereditary testing is to recognize the hereditary explanation behind the reason for an illness, affirm a suspected finding, expectation of future malady, to distinguish when an individual might pass his/her genetic data to kids, and to foresee treatment reaction in a patient. Hereditary testing is additionally used to screen new-conceived babies, hatchlings, or developing lives utilized as a part of vitro treatment for hereditary imperfections. The hereditary testing business sector is ordered in light of its applications into pharmacogenomics testing, prescient testing, pre-birth and neonatal testing.

Track 29: Medical genetics

Medical genetics is the branch of medicine that involves the diagnosis and management of hereditary disorders. Medical genetics differs from human genetics in that human genetics is a field of scientific research that may or may not apply to medicine, while medical genetics refers to the application of genetics to medical care. For example research on the causes and inheritance of genetic disorders would be considered within both human genetics and medical genetics, while the diagnosis, management, and counselling people with genetic disorders would be considered part of medical genetics.

In contrast, the study of typically non-medical phenotypes such as the genetics of eye color would be considered part of human genetics, but not necessarily relevant to medical genetics (except in situations such as albinism). Genetic medicine is a newer term for medical genetics and incorporates areas such as gene therapy, personalized medicine, and the rapidly emerging new medical specialty, predictive medicine.

Track 30: Personalised genomics

Personal genomics is the branch of genomics concerned with the sequencing and analysis of the genome of an individual. The genotyping stage employs different techniques, including single-nucleotide polymorphism (SNP) analysis chips, or partial or full genome sequencing. Once the genotypes are known, the individual's genotype can be compared with the published literature to determine likelihood of trait expression and disease risk.

In pharmacogenomics genetic information can be used to select the most appropriate drug to prescribe to a patient. The drug should be chosen to maximize the probability of obtaining the desired result in the patient and minimize the probability that the patient will experience side effects. Genetic information may allow physicians to tailor therapy to a given patient, in order to increase drug efficacy and minimize side effects.

5th International Conference and Exhibition on Metabolomics, May 16-18, 2016 Osaka, International Conference on Genetic Counselling and Genomic Medicine August 11-12, 2016 Birmingham; Japan; 5th International Conference on Tissue Science and Regenerative Medicine September 12-14, 2016 Berlin, Germany; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; International Conference on Clinical and Molecular Genetics, November 28-30, 2016 Chicago, USA; Golden Helix Symposium, January 14-16, 2016, Mansoura, Egypt; The Personalized Medicine, World Conference 24-27 January, 2016, San Francisco, USA; 14th Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine Congress, November 26-29, 2016,Taipei, Taiwan; Personalized Medicine, July 10-15, 2016, Hong Kong, China; 18th International Conference on Pharmaceutical Engineering and Pharmacogenetics, March 30 - 31, 2016, Istanbul, Turkey

About Conference

The International Conference on Genetic Counselling & Genomic Medicine which is going to be held during December 07-08,2016,Madrid, Spain will bring together world-class personalities working on stem cells, genetic disorders and regenerative medicine. Genetic counseling provides information and support to people who have, or may be at risk for, genetic disorders. Genomic Medicine-2016 provides a platform where you can meet top notch experts in the field and Genetic Counselors and experts in the field to discuss genetic risks. The counseling may be for yourself or a family member.

Genomic Medicine is an emerging medical discipline that involves using genomic information about an individual as part of their clinical care (e.g., for diagnostic or therapeutic decision-making) and the health outcomes and policy implications of that clinical use. Already, genomic medicine is making an impact in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious disease. In Genomic Medicine-2016, you can make ytour self familiar with it for the betterment of your future.

Why to attend???

Name: International Conference on Genetic Counseling and Genomic Medicine
Start: 2018-02-12
End: 2018-02-13
Location: Dubai, UAE

Meet Your Target Market With members from around the world focused on learning about Advertising and marketing, this is the single best opportunity to reach the largest assemblage of participants from the Genetic counseling and Genomic medicine community. The two days event implants a firm relation of upcoming strategies in the field of Genetic counseling and Genomic medicine with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.Conduct demonstrations, distribute information, meet with current and potential customers, make a splash with a new product line, and receive name recognition.

Our Conference will provide a perfect platform addressing:

Innovative talks by the experts of the global scientific community
Sterling workshop sessions
Remarkable Awards and Global Recognition to meritorious Researcher
Global Networking with 50+ Countries
Novel Techniques to Benefit Your Research
Global Business and Networking Opportunities
Exquisite Platform for showcasing your products and International Sponsorship

See more at: genomicmedicine.conferenceseries.com

Conference Highlights

Genetic Medicine
Genomic Counselling
Clinical genomics-impact and utility
Integration of genomics data
Clinical applications and diagnostics
Genome editing and engineering
Next generation sequencing
Genomic medicine-role in oncology
Clinical genomics
Molecular Medicine
Cyto Genetics
Evolution of Noval Genes

Target Audience:

Physicians
Health care professional of all disciplines interested in the future of medicine
Human Geneticists
Genomic Scientists
Researchers

Market Analysis

The International Conference on Genetic Counseling & Genomic Medicine which is going to be held during December 07-08, 2016,Madrid, Spain will bring together world-class personalities working on stem cells, genetic disorders and regenerative medicine. Genetic counseling provides information and support to people who have, or may be at risk for, genetic disorders. Genomic Medicine-2016 provides a platform where you can meet top notch experts in the field and Genetic Counselors and experts in the field to discuss genetic risks.

For more details please visit: http://genomicmedicine.conferenceseries.com/

Why Madrid?

Madrid is the capital and largest city of Spain. The population of the city is almost 3.2 million and that of the Madrid metropolitan area, around 6.3 million. It is the third-largest city in the European Union, after London and Berlin, and its metropolitan area is the third-largest in the European Union after London and Paris. The city spans a total of 604.3 km2 (233.3 sq mi).

The city is located on the Manzanares River in the centre of both the country and the Community of Madrid (which comprises the city of Madrid, its conurbation and extended suburbs and villages); this community is bordered by the autonomous communities of Castile and León and Castile-La Mancha. As the capital city of Spain, seat of government, and residence of the Spanish monarch, Madrid is also the political, economic and cultural centre of Spain. The current mayor is Ana Botella from the People's Party (PP).

The Madrid urban agglomeration has the third-largest GDP in the European Union and its influences in politics, education, entertainment, environment, media, fashion, science, culture, and the arts all contribute to its status as one of the world's major global cities. Due to its economic output, high standard of living, and market size, Madrid is considered the major financial centre of Southern Europe and the Iberian Peninsula; it hosts the head offices of the vast majority of the major Spanish companies, such as Telefónica, Iberia or Repsol. Madrid is the 17th most livable city in the world according to Monocle magazine, in its 2014 index.

Conference Highlights

Genomic Medicine
Genetic Counseling
Clinical genomics-impact and utility
Integration of genomics data
Clinical applications and diagnostics
Genome editing and engineering
Next generation sequencing
Genomic medicine-role in oncology
Clinical genomics
Molecular Medicine
Cyto Genetics
Evolution of Noval Genes

Glance at Global Economic Market:

The global market for genomic medicine is expected to reach USD 22.1 billion by 2020, growing at an estimated CAGR of 10.3% from 2014 to 2020, according to a new study by Grand View Research, Inc. Genomic medicine play an imperative role in the field of infectious disease testing by enabling the use of fast and effective result rendering molecular diagnostic tests. This, coupled with growing prevalence of infectious diseases and hospital acquired infections is expected to drive market growth during the forecast period. Other driving factors for this market include decreasing prices of DNA sequencing, increasing demand for genome analysis in animal and plant feedstock, extensive presence of both private and public external funding programs and growing patient awareness levels. In addition, presence of untapped growth opportunities in emerging countries such as India, Brazil and China and the increasing health awareness are expected to serve this market as future growth opportunities.

Genomic medicine based diagnostics dominated the overall market in terms of revenue at 36.4% in 2013 majorly owing to the presence of a relatively larger number of R&D programs. Genomic medicine based personalized medicine segment on the other hand is expected to grow at the fastest CAGR of over 12.0% from 2014 to 2020 due to increasing demand for population based therapeutic solutions and subsequent increase in R&D initiatives.

Why to attend???

Major Marketing Associations in Europe

Target Audience:

Presidents or Vice Presidents/ Directors of Associations and Societies, CEO’s of the companies associated with Genetic counseling and Genomic medicine Consumer Products. Retailers, Marketing, Advertising and Promotion Agency Executives, Solution Providers (digital and mobile technology, P-O-P design, retail design, and retail execution), Professors and Students from Academia in the study of Marketing and Advertising filed.

Target Audience:

Industry 40%

Academia 50%

Others 10%

Genomics Related Socieites:

Funding Agencies:

Past Conference Report

Genomics 2015

OMICS International hosted 3^rd International Conference on Genomics & Pharmacogenomics during September 21-23, 2015 at San Antonio, USA based on the theme “Implications & Impacts of Genomic Advances on Global Health”.

Active participation and generous response was received from the Organizing Committee Members, scientists, researchers, as well as experts from Non-government organizations, and students from diverse groups who made this conference as one of the most successful and productive events in 2015 from OMICS Group.

The conference was marked with several workshops, multiple sessions, Keynote presentations, panel discussions and Poster sessions. We received active participation from scientists, young and brilliant researchers, business delegates and talented student communities representing more than 35 countries, who have driven this event into the path of success.

The conference was initiated with a warm welcome note by Honorable guests and the Keynote forum. The proceedings went through interactive sessions and panel discussions headed by honorable Moderator Dr. Aditi Nadkarni, New York University, USA for the conference.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers:

Utilizing cancer sequencing in the clinic - Best practices in variant analysis, filtering and annotation: Andreas Scherer, Golden Helix Inc., USA

The role of genomics in gene therapy and diagnostic testing and related intellectual property issues: Krishna Dronamraju, Foundation for Genetic Research, USA

Epigenesis, methylation, and single strand breaks: Rosemarie Wahl, St. Mary's University, USA

The application of validation and proficiency testing concepts from current clinical genetic diagnostics for the implementation of new genetic technologies: Kathleen S Wilson, U.T Southwestern Medical Center, USA

Biomimetic membranes: Mariusz Grzelakowski, Applied Biomimetic Inc., USA

The Genomics-2015 also being highlighted for the below International workshop:

Understanding the effects of steroid hormone exposure on regulation of P53 and Bcl-2 gene expression

OMICS Group has taken the privilege of felicitating Genomics-2015 Organizing Committee, Keynote Speakers who supported for the success of this event. OMICS Group, on behalf of the Organizing Committee congratulates the Best Poster awardees for their outstanding performance in the field of Genomics & Pharmacogenomics and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

Poster Judging was done by: Dr. Hao Mei, University of Mississippi Medical Center, USA
Best Poster Award was received by: Mr. Juan Carlos Alberto Padilla, Instituto Politecnico Nacional, Mexico

Genomics-2015 attracted the Society for General Microbiology, UK and they came forward to advert their leading journals on the back side cover of conference proceedings book.

Genomics-2015 was sponsored by one of the leading bioinformatics solution center BGI Americas, USA

Genomics-2015 necessarily thanks Aeon Clinical Laboratories, USA for exhibiting recent innovations and express ways in clinical testing.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Genomics-2015.

With the unique feedback from the conference, Conferenceseries LLC would like to announce the commencement of the International conference on Genetic Counseling and Genomic Medicine, December 07-08, 2016, Madrid, Spain

For More details visit: http://genomicmedicine.conferenceseries.com/

Past Reports Gallery

To Collaborate Scientific Professionals around the World

Conference Date February 12-13, 2018

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Past Conference Report

Genomics 2015 Conference

Supported By

Journal of Clinical & Medical Genomics Journal of Pharmacogenomics & Pharmacoproteomics

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Genetic Counseling and Genomic Medicine

February 12-13, 2018 Madrid, Spain

Novel research on Genetic Counseling and Genomic medicine for Global Health

Genomic Medicine conference 2016 |Madrid | Spain | CPD Events |Genomic Medicine Conferences 2016 | 2017

Conference Series Conferences gaining more Readers and Visitors

Renowned Speakers

Dr. Gopal B. Krishnan

Dr. Peter Lajos Nagy

Dr. Igor A. Sobenin

Dr. Rosemarie Wahl

Dr. Patricia Berg

Margarita A Sazonova

Dr. Mariusz Grzelakowski

Dr. Kathleen Wilson

Recommended Global Genetics & Molecular Biology Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Genomic Medicine-2016

Sessions and tracks

About Conference

Why to attend???

Market Analysis

Why to attend???

Target Audience:

Target Audience:

Past Conference Report

To Collaborate Scientific Professionals around the World

Useful Links

Past Conference Report

Supported By

Past Affiliations